Oncotelic Therapeutics Inc · OTC:OTLC
Oncotelic Therapeutics — Merger or Acquisition (August 2021)
6 slides from Oncotelic Therapeutics's merger presentation, Aug 17, 2021
Slide 1: GMP/Oncotelic Transaction Investor Presentation
GMPY/ Oncotelic Transaction — Investor Presentation 8-16-2021 WWW.ONCOTELIC.COM ONCOTELIC
Slide 2: Forward-looking Statements
Forward-looking Statements * This document contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in t
Slide 3: Drug Development takes >10 yrs and >$2 Billion
Drug Development takes >10 yrs and > 2Billion * The development of a new drugisaverylengthy Traditional drug R&D takes >10 years and >$2B* and complex process that —— can cost billions of dollars. It is one of those processes where the probability of failure is Tar — greater than the : optimization
Slide 4: Mateon (aka Oxigene) history
‘ONCOTELIC Mateon (aka Oxigene) history Mateon (aka Oxigene) since 2004-2019 has spent $279Million on its pipeline (Oxi4503 and CA4P) Oncotelic (previously Antisense Pharma) has spend close to $80Million on OT-101. To complete the development of the pipeline we are looking at another $100M per indic
Slide 5: GMP/Oncotelic JV as win/win option
GMP/ Oncotelic JV as win/win option The JV is between GMP and Oncotelic and Dr. Trieu The JV shall be fully funded by GMP Dr. Trieu will provide manufacturing to support the commercialization of Oncotelic's assets as well as building out a pipeline of fast to market portfolio of drugs Oncotelic will
Slide 6: Conclusions
ONCOTELIC Conclusions Traditional Financing GMP/Oncotelic JV Amount Raise S50M > 2 yrs/ >100M % Dilution 75% 0% % Haircut 50% 0% Potential Upside (0) 7-14X Net Outcome/ Shareprice The proposed terms are being finalized as part of the definitive agreement within the next 45 days for shareholder appro
Oncotelic Therapeutics — Merger or Acquisition (August 2021) on 6ix